Narith N. Ou

13.7k total citations
23 papers, 465 citations indexed

About

Narith N. Ou is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Internal Medicine. According to data from OpenAlex, Narith N. Ou has authored 23 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 6 papers in Geriatrics and Gerontology and 5 papers in Internal Medicine. Recurrent topics in Narith N. Ou's work include Atrial Fibrillation Management and Outcomes (9 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Narith N. Ou is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Narith N. Ou collaborates with scholars based in United States, Algeria and Australia. Narith N. Ou's co-authors include Julie L. Cunningham, Kristen McCullough, Christine M. Formea, Wayne T. Nicholson, Joanna L. Stollings, Maria I. Rudis, Lance J. Oyen, Dennis M. Manning, John G. O’Meara and Paul R. Daniels and has published in prestigious journals such as Journal of the American College of Cardiology, Critical Care Medicine and The American Journal of Cardiology.

In The Last Decade

Narith N. Ou

21 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narith N. Ou United States 11 186 175 105 73 72 23 465
Sze Ling Chan Singapore 13 127 0.7× 29 0.2× 66 0.6× 45 0.6× 40 0.6× 58 474
Miguel Gil Spain 13 54 0.3× 156 0.9× 61 0.6× 23 0.3× 47 0.7× 37 643
Michael Ward Australia 11 80 0.4× 107 0.6× 62 0.6× 13 0.2× 23 0.3× 50 436
Edmund J. Pezalla United States 10 30 0.2× 171 1.0× 55 0.5× 77 1.1× 17 0.2× 25 527
Jonathan Thigpen United States 8 79 0.4× 131 0.7× 20 0.2× 57 0.8× 14 0.2× 19 295
Antonio Ciaccia Canada 10 39 0.2× 267 1.5× 21 0.2× 138 1.9× 25 0.3× 16 473
Anders Helldén Sweden 11 45 0.2× 56 0.3× 47 0.4× 22 0.3× 67 0.9× 23 417
Ghadeer K. Dawwas United States 14 23 0.1× 193 1.1× 15 0.1× 125 1.7× 26 0.4× 35 626
Mònica Sabaté Spain 13 70 0.4× 36 0.2× 53 0.5× 5 0.1× 34 0.5× 37 406
Ariola Koci Italy 10 60 0.3× 111 0.6× 47 0.4× 19 0.3× 14 0.2× 16 386

Countries citing papers authored by Narith N. Ou

Since Specialization
Citations

This map shows the geographic impact of Narith N. Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narith N. Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narith N. Ou more than expected).

Fields of papers citing papers by Narith N. Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narith N. Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narith N. Ou. The network helps show where Narith N. Ou may publish in the future.

Co-authorship network of co-authors of Narith N. Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Narith N. Ou. A scholar is included among the top collaborators of Narith N. Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narith N. Ou. Narith N. Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanwar, Ardaas, Narith N. Ou, Philip J. Spencer, et al.. (2024). Reduction in Balloon Pump Size Reduces Axillary Intraaortic Balloon Pump Failure Risk. ASAIO Journal. 71(1). 68–74.
2.
Chaudhary, Rahul, Amteshwar Singh, Damon E. Houghton, et al.. (2022). Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage. JAMA Network Open. 5(11). e2240145–e2240145. 48 indexed citations
3.
Sanborn, D. M., Alan Sugrue, Mustapha Amin, et al.. (2021). Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications. The American Journal of Cardiology. 162. 80–85. 7 indexed citations
4.
Jentzer, Jacob C., et al.. (2021). Pain Associated With Continuous Intravenous Infusion of Bumetanide: A Case Series. Critical Care Nurse. 41(2). 44–50. 1 indexed citations
5.
Ou, Narith N., et al.. (2019). Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?. Clinical Cardiology. 43(2). 137–144. 17 indexed citations
6.
O’Meara, John G., Narith N. Ou, Jennifer L. Osborn, et al.. (2019). Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping. Vascular Medicine. 25(1). 47–54. 10 indexed citations
7.
Smith, Zachary, Jennifer Barrow, Danielle Carter, et al.. (2019). Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method. American Journal of Health-System Pharmacy. 76(3). 153–165. 6 indexed citations
8.
Ou, Narith N., et al.. (2018). EVALUATING THE SAFETY OF CONCURRENT INTRAVENOUS HEPARIN WITH INTRAVENOUS ALTEPLASE IN PATIENTS WITH VALVE THROMBOSIS: A CASE SERIES. Journal of the American College of Cardiology. 71(11). A2123–A2123.
9.
10.
Nei, Andrea M., et al.. (2018). Comparison of Warfarin Requirements in Post-cardiac Surgery Patients: Valve Replacement Versus Non-valve Replacement. American Journal of Cardiovascular Drugs. 18(3). 223–229. 8 indexed citations
11.
12.
Formea, Christine M., Wayne T. Nicholson, Kristen McCullough, et al.. (2013). Development and Evaluation of a Pharmacogenomics Educational Program for Pharmacists. American Journal of Pharmaceutical Education. 77(1). 10–10. 67 indexed citations
13.
O’Meara, John G., Narith N. Ou, Paul R. Daniels, et al.. (2013). Risk Factors for Excessive Anticoagulation Among Hospitalized Adults Receiving Warfarin Therapy Using a Pharmacist‐Managed Dosing Protocol. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(11). 1165–1174. 11 indexed citations
14.
McCullough, Kristen, Christine M. Formea, Julie L. Cunningham, et al.. (2011). Assessment of the Pharmacogenomics Educational Needs of Pharmacists. American Journal of Pharmaceutical Education. 75(3). 51–51. 155 indexed citations
15.
Qian, Qi, et al.. (2010). ACEi/ARB for systolic heart failure: Closing the quality gap with a sustainable intervention at an academic medical center. Journal of Hospital Medicine. 6(3). 156–160. 15 indexed citations
16.
17.
Rea, Rhonda S., Sandra L. Kane‐Gill, Maria I. Rudis, et al.. (2006). Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias*. Critical Care Medicine. 34(6). 1617–1623. 27 indexed citations
18.
Oyen, Lance J., et al.. (2005). Effectiveness of a Computerized System for Intravenous Heparin Administration: Using Information Technology to Improve Patient Care and Patient Safety. The American Heart Hospital Journal. 3(2). 75–81. 10 indexed citations
19.
Wilson, John, Lance J. Oyen, Narith N. Ou, et al.. (2005). Hospital rules-based system: The next generation of medical informatics for patient safety. American Journal of Health-System Pharmacy. 62(5). 499–505. 23 indexed citations
20.
Ou, Narith N., et al.. (2002). Current indications for ACE inhibitors and HOPE for the future.. PubMed. 8(5). 478–90; quiz 491. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sze Ling Chan Breakdown of academic impact, for papers by Miguel Gil Breakdown of academic impact, for papers by Michael Ward Breakdown of academic impact, for papers by Edmund J. Pezalla Breakdown of academic impact, for papers by Jonathan Thigpen Breakdown of academic impact, for papers by Antonio Ciaccia Breakdown of academic impact, for papers by Anders Helldén Breakdown of academic impact, for papers by Ghadeer K. Dawwas Breakdown of academic impact, for papers by Mònica Sabaté Breakdown of academic impact, for papers by Ariola Koci
Rankless by CCL
2026